According to the Zhitong Finance App, JD Health (06618.HK) announced interim results for the six months ended June 30, 2026. The group obtained revenue of RMB 40.888 billion (same unit), an increase of 15.9%; non-IFRS operating profit for the period was RMB 3.483 billion, up 40.3% year on year; profit attributable to the company owner was RMB 3.437 billion, up 32.37% year on year; basic profit per share was RMB 1.08 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.